151 related articles for article (PubMed ID: 27864508)
1. Radiotherapy using IMRT boosts after hyperbaric oxygen therapy with chemotherapy for glioblastoma.
Yahara K; Ohguri T; Udono H; Yamamoto J; Tomura K; Onoda T; Imada H; Nishizawa S; Korogi Y
J Radiat Res; 2017 May; 58(3):351-356. PubMed ID: 27864508
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine, nimustine, and vincristine) for high-grade gliomas: long-term results.
Ogawa K; Ishiuchi S; Inoue O; Yoshii Y; Saito A; Watanabe T; Iraha S; Toita T; Kakinohana Y; Ariga T; Kasuya G; Murayama S
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):732-8. PubMed ID: 21420247
[TBL] [Abstract][Full Text] [Related]
3. A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma.
Morganti AG; Balducci M; Salvati M; Esposito V; Romanelli P; Ferro M; Calista F; Digesù C; Macchia G; Ianiri M; Deodato F; Cilla S; Piermattei A; Valentini V; Cellini N; Cantore GP
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):92-7. PubMed ID: 19683876
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy after hyperbaric oxygenation in malignant gliomas.
Chen JR; Xu HZ; Ding JB; Qin ZY
Curr Med Res Opin; 2015 Nov; 31(11):1977-84. PubMed ID: 26414129
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.
Chen C; Damek D; Gaspar LE; Waziri A; Lillehei K; Kleinschmidt-DeMasters BK; Robischon M; Stuhr K; Rusthoven KE; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1066-74. PubMed ID: 20932651
[TBL] [Abstract][Full Text] [Related]
6. Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis.
Panet-Raymond V; Souhami L; Roberge D; Kavan P; Shakibnia L; Muanza T; Lambert C; Leblanc R; Del Maestro R; Guiot MC; Shenouda G
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):473-8. PubMed ID: 18554821
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma.
Paulino AC; Mazloom A; Terashima K; Su J; Adesina AM; Okcu MF; Teh BS; Chintagumpala M
Cancer; 2013 Jul; 119(14):2654-9. PubMed ID: 23633429
[TBL] [Abstract][Full Text] [Related]
8. A phase I dose escalation study using simultaneous integrated-boost IMRT with temozolomide in patients with unifocal glioblastoma.
Truc G; Bernier V; Mirjolet C; Dalban C; Mazoyer F; Bonnetain F; Blanchard N; Lagneau É; Maingon P; Noël G
Cancer Radiother; 2016 May; 20(3):193-8. PubMed ID: 27117900
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas.
Ogawa K; Yoshii Y; Inoue O; Toita T; Saito A; Kakinohana Y; Adachi G; Iraha S; Tamaki W; Sugimoto K; Hyodo A; Murayama S
Br J Cancer; 2006 Oct; 95(7):862-8. PubMed ID: 16953239
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials.
Carlson JA; Reddy K; Gaspar LE; Ney D; Kavanagh BD; Damek D; Lillehei K; Chen C
J Neurooncol; 2015 Jun; 123(2):251-7. PubMed ID: 25920710
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.
Franco P; Mistrangelo M; Arcadipane F; Munoz F; Sciacero P; Spadi R; Migliaccio F; Angelini V; Bombaci S; Rondi N; Numico G; Ragona R; Cassoni P; Morino M; Racca P; Ricardi U
Cancer Invest; 2015 Jul; 33(6):259-66. PubMed ID: 25950188
[TBL] [Abstract][Full Text] [Related]
12. Prospective trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas.
Ogawa K; Yoshii Y; Inoue O; Toita T; Saito A; Kakinohana Y; Adachi G; Ishikawa Y; Kin S; Murayama S
Radiother Oncol; 2003 Apr; 67(1):63-7. PubMed ID: 12758241
[TBL] [Abstract][Full Text] [Related]
13. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
14. Systemic chemotherapy using paclitaxel and carboplatin plus regional hyperthermia and hyperbaric oxygen treatment for non-small cell lung cancer with multiple pulmonary metastases: preliminary results.
Ohguri T; Imada H; Narisada H; Yahara K; Morioka T; Nakano K; Miyaguni Y; Korogi Y
Int J Hyperthermia; 2009 Mar; 25(2):160-7. PubMed ID: 19337916
[TBL] [Abstract][Full Text] [Related]
15. Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era.
Byun HK; Kim N; Yoon HI; Kang SG; Kim SH; Cho J; Baek JG; Chang JH; Suh CO
Radiat Oncol; 2019 Mar; 14(1):51. PubMed ID: 30917849
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes and dose-volume histogram analysis of simultaneous integrated boost method for malignant gliomas using intensity-modulated radiotherapy.
Nakamatsu K; Suzuki M; Nishimura Y; Kanamori S; Koike R; Shibata T; Shintani N; Okumura M; Okajima K; Akai F
Int J Clin Oncol; 2008 Feb; 13(1):48-53. PubMed ID: 18307019
[TBL] [Abstract][Full Text] [Related]
17. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
[TBL] [Abstract][Full Text] [Related]
18. Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphoma.
Filippi AR; Ciammella P; Piva C; Ragona R; Botto B; Gavarotti P; Merli F; Vitolo U; Iotti C; Ricardi U
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):370-5. PubMed ID: 24613810
[TBL] [Abstract][Full Text] [Related]
19. Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme.
Fuller CD; Choi M; Forthuber B; Wang SJ; Rajagiriyil N; Salter BJ; Fuss M
Radiat Oncol; 2007 Jul; 2():26. PubMed ID: 17629934
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme.
Reddy K; Damek D; Gaspar LE; Ney D; Waziri A; Lillehei K; Stuhr K; Kavanagh BD; Chen C
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):655-60. PubMed ID: 22483738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
